MRI changes and ApoE genotype, a prospective 1-year follow-up of traumatic brain injury: A pilot study

Brain Injury

Volumn 21, Issue 12, 2007, Pages 1307-1314

  Hiekkanen, Heli ^a   Kurki, Timo ^a   Brandstack, Nina ^a   Kairisto, Veli ^a   Tenovuo, Olli ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apolipoprotein E genotype; Magnetic resonance imaging; Traumatic brain injury

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; ARTICLE; BRAIN CONTUSION; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INJURY SEVERITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TRAUMATIC BRAIN INJURY;

EID: 38849207777     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050701739549     Document Type: Article

References (70)

1. Teasdale, GM, Nicoll, JA, Murray, G. and Fiddes, M. (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet, 350, pp. 1069-1071.
2. Sorbi, S., Nacmias, B. and Piacentini, S. (1995) ApoE as a prognostic factor for posttraumatic coma. Nature Medicine, 1, p. 852.
3. Friedman, G., Froom, P. and Sazbon, L. (1999) Apolipoprotein E-e4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology, 52, pp. 244-248.
4. Lichtman, SW, Seliger, G., Tycko, B. and Marder, K. (2000) Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology, 55, pp. 1536-1539.
5. Crawford, FC, Vanderploeg, RD and Freeman, MJ (2002) APOE genotype influences acquisition and recall following traumatic brain injury. Neurology, 58, pp. 1115-1118.
6. Teasdale, GM, Murray, GD and Nicoll, JA (2005) The association between APOE e4, age and outcome after head injury: A prospective cohort study. Brain, 128, pp. 2556-2561.
7. Alexander, S., Kerr, ME, Kim, Y., Kamboh, MI, Beers, SR and Conley, YP (2007) Apolipoprorein E4 allele presence and functional outcome after severe traumatic brain injury. Journal of Neurotrauma, 24, pp. 790-797.
8. Graham, DI, Horsburgh, K. and Nicoll, JAR (1999) Apolipoprotein E and the response of the brain to injury. Acta Neurochirgica, 73, pp. 89-92.
9. Horsburgh, K., McCarron, MO, White, F. and Nicoll, JA (2000) The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: Evidence of common mechanisms and utility of animal models. Neurobiology of Aging, 21, pp. 245-255.
10. Sabo, T., Lomnitski, L. and Nyska, A. (2000) Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience, 101, pp. 879-884.
11. Millar, K., Nicoll, JA, Thornhill, S., Murray, GD and Teasdale, GM (2003) Long term neuropsychological outcome after head injury: Relation to APOE genotype. Journal of Neurology, Neurosurgery and Psychiatry, 74, pp. 1047-1052.
12. Smith, C., Graham, DI, Murray, LS, Stewart, J. and Nicoll, JA (2006) Association of APOE e4 and cerebrovascular pathology in traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry, 77, pp. 363-366.
13. Ariza, M., Pueyo, R. and Mdel, M Matarin (2006) Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry, 77, pp. 1191-1193.
14. Laskowitz, DT, Sheng, H., Bart, RD, Joyner, KA, Roses, AD and Warner, DS (1997) Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. Journal of Cerebral Blood Flow Metabolism, 17, pp. 753-758.
15. Poirier, J., Baccichet, A., Dea, D. and Gauthier, S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience, 55, pp. 81-90.
16. Kay, AD, Day, SP, Kerr, M., Nicoll, JA, Packard, CJ and Caslake, MJ (2003) Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. Journal of Neurotrauma, 20, pp. 717-723.
17. Nicoll, JA, Roberts, GW and Graham, DI (1995) Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Medicine, 1, pp. 135-137.
18. Graham, DI, Gentleman, SM and Nicoll, AR (1999) Is there a genetic basis for the deposition of b-amyloid after fatal head injury?. Cell Molecular Neurobiology, 19, pp. 19-30.
19. Lee, Y., Aono, M., Laskowitz, DT, Warner, DS and Pearlstein, RD (2004) Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate. Neurochemistry International, 44, pp. 107-118.
20. Laskowitz, DT, Goel, B., Bennett, ER and Matthew, WD (1997) Apolipoprotein E suppresses glial cell secretion of TNF alpha. Journal of Neuroimmunology, 76, pp. 70-74.
21. Laskowitz, DT, Mathews, WD and Bennett, BR (1998) Endogenous Apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuro Report, 9, pp. 615-618.
22. Grocott, HP, Newman, MF, Moalem, H El, Bainbridge, D., Butler, A. and Laskowitz, DT (2001) Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 122, pp. 622-623.
23. Kerr, ME, Kraus, M., Marion, D. and Kamboh, I. (1999) Evaluation of apolipoprotein E genotypes on cerebral blood flow, metabolism following traumatic brain injury. Oxygen transport to tissue XXI, pp. 117-124. Plenum Press, New York
24. Strittmatter, WJ, Saunders, AM and Goedert, M. (1994) Isoform-spesific interactions of apolipoprotein E with microtubule - associated protein tau: Implications for Alzheimer disease. Proceedings if the National Academy of Sciences (USA), 91, pp. 11183-11186.
25. Bellosta, S., Nathan, BP, Orth, M., Dong, LM, Mahley, RW and Pitas, RE (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. Journal of Biological Chemistry, 270, pp. 27063-27071.
26. Fullerton, SM, Shirman, GA, Strittmatter, WJ and Matthew, WD (2001) Impairment of the blood-nerve and blood-brain barriers in Apolipoprotein E knockout mice. Experimental Neurology, 169, pp. 13-22.
27. Lynch, JR, Pineda, JA and Morgan, D. (2002) Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Annals of Neurology, 51, pp. 113-117.
28. Ti, LK, Mackensen, GB and Grocott, HP (3003) Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. Journal of Thoracic and Cardiovascular Surgery, 125, pp. 211-213.
29. Weir, CJ, McCarron, MO and Muir, KW (2001) Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology, 57, pp. 1097-1100.
30. Rugg-Gunn, FJ, Symms, MR and Barker, GJ (2001) Diffusion imaging shows abnormalities after blunt head trauma when conventional magnetic resonance imaging is normal. Journal of Neurology, Neurosurgery and Psychiatry, 70, pp. 530-533.
31. MacKenzie, JD, Siddiqi, F. and Babb, JS (2002) Brain atrophy in mild or moderate traumatic brain injury: A longitudinal quantitative analysis. AJNR: American Journal of Neuroradiology, 23, pp. 1509-1515.
32. Tomaiuolo, F., Carlesimo, GA and Paola, M Di (2004) Gross morphology and morphometric sequelae in the hippocampus, fornix, and corpus callosum of patients with severe non-missile traumatic brain injury without macroscopically detectable lesions: A T1 weighted MRI study. Journal of Neurology, Neurosurgery and Psychiatry, 75, pp. 1314-1322.
33. Arfanakis, K., Haughton, VM and Carew, JD (2002) Diffusion tensor MR imaging in diffuse axonal injury. AJNR: American Journal of Neuroradiology, 23, pp. 794-802.
34. Friedman, SD, Brooks, WM and Jung, RE (1999) Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology, 52, pp. 1384-1391.
35. Son, BC, Park, CK and Choi, BG (2000) Metabolic changes in pericontusional oedematous areas in mild head injury evaluated by1H MRS. Acta Neurochirgica, 76, pp. 13-16.
36. Assaf, Y., Beit-Yannai, E., Shohami, E., Berman, E. and Cohen, Y. (1997) Diffusion- and T2-weighted MRI of close-head injury in rats: A time course study and correlation with histology. Journal of Magnetic Resonance Imaging, 15, pp. 77-85.
37. Ezaki, Y., Tsutsumi, K., Morikawa, M. and Nagata, I. (2006) Lesions identified on T2*-weighted gradient echo images in two patients with suspected diffuse axonal injury that resolved in less than ten days. Acta Neurochirgica (Wien), 148, pp. 547-550.
38. Jennett, B. and Bond, M. (1975) Assessment of outcome after severe brain damage: A practical scale. Lancet, pp. 480-484.
39. King, NS, Crawford, S. and Wenden, FJ (1997) Measurement of post-traumatic amnesia: How reliable is it?. Journal of Neurology, Neurosurgery and Psychiatry, 62, pp. 38-42.
40. McFarland, K., Jackson, L. and Geffe, G. (2001) Post-traumatic amnesia: Consistency-of-recovery and duration-to-recovery following traumatic brain impairment. Clinical Neuropsychology, 15, pp. 59-68.
41. Kay, T., Harrington, DE and Adams, R. (1993) Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation, 8, pp. 86-87.
42. Donohoe, GG, Laaksonen, M. and Pulkki, K. (2000) Rapid single-tube screening of the C282Y hemochromatosis mutation by real-time multiplex allele-specific PCR without fluorescent probes. Clinical Chemistry, 46, pp. 1540-1547.
43. Donohoe, GG, Salomäki, A. and Lehtimäki, T. (1999) Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clinical Chemistry, 45, pp. 143-146.
44. Evans Jr, WA (1942) An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Archives of Neurology and Psychiatry, 42, pp. 931-937.
45. Scheltens, P., Barkhof, F. and Leys, D. (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. Journal of Neurological Science, 114, pp. 7-12.
46. Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. and Utermann, G. (1986) Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations. Journal of Lipid Research, 27, pp. 227-235.
47. Mauch, DH, Nagler, K. and Schumacher, S. (2001) CNS synaptogenesis promoted by glia-derivated cholesterol. Science, 294, pp. 1354-1357.
48. White, F., Nicoll, JA, Roses, AD and Horsburgh, K. (2001) Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease, 8, pp. 611-625.
49. Lynch, JR, Tang, W. and Wang, H. (2003) APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. Journal of Biological Chemistry, 278, pp. 48529-48533.
50. Laskowitz, DT, Thekdi, AD and Thekdi, SD (2001) Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Experimental Neurology, 167, pp. 74-85.
51. Heesen, C., Nawrath, L., Reich, C., Bauer, N., Schulz, KH and Gold, SM (2006) Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour?. Journal of Neurology, Neurosurgery and Psychiatry, 77, pp. 34-39.
52. Sundström, A., Nilsson, LG, Cruts, M., Adolfsson, R., Van Broeckhoeven, C. and Nyberg, L. (2007) Fatigue before and after mild traumatic brain injury: Pre-post-injury comparisons in relation to Apolipoprotein E. Brain Injury, 21, pp. 1049-1054.
53. Mui, S., Briggs, M. and Chung, H. (1996) A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with epsilon 4 allele. Neurology, 47, pp. 196-201.
54. Lambert, JC, Pasquier, F. and Cottel, D. (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Human Molecular Genetics, 7, pp. 533-540.
55. Artiga, MJ, Bullido, MJ and Frank, A. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Letters, 421, pp. 105-108.
56. Bullido, MJ, Artiga, MJ and Recuero, M. (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nature of Genetics, 18, pp. 69-71.
57. Lambert, JC, Berr, C. and Pasquier, F. (1998) Pronounced impact of Th1/ E47 cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Human Molecular Genetics, 7, pp. 1511-1516.
58. Lambert, JC, Brousseau, T. and Defosse, V. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - the ECTIM study. Human Molecular Genetics, 9, pp. 57-61.
59. Roks, G., Cruts, M. and Houwing-Duistermaat, JJ (2002) Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam study. American Journal of Medical Genetics, 114, pp. 570-573.
60. Laws, SM, Taddei, K. and Martins, G. (1999) The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport, 10, pp. 879-882.
61. Laws, SM, Taddei, K. and Martins, G. (2002) Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Molecular Psychiatry, 7, pp. 886-890.
62. Lambert, JC, Araria-Goumidi, L. and Myllykangas, L. (2002) Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology, 59, pp. 59-66.
63. Heijmans, BT, Slagboom, PE and Gussekloo, J. (2002) Association of APOE epsilon2/epsilon3/epsilon 4 and promoter gene variants with dementia but not cardiovascular mortality in old age. American Journal of Medical Genetics, 107, pp. 201-208.
64. Lambert, JC, Mann, D. and Goumidi, L. (2001) Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease. Lancet, 357, pp. 608-609.
65. Berr, C., Lambert, JC and Sazdovitch, V. (2001) Neuropathological epidemiology of cerebral aging: A study of two genetic polymorphisms. Neurobiology of Aging, 22, pp. 227-235.
66. Myllykangas, L., Polvikoski, T. and Reunanen, K. (2002) ApoE epsilon 3-haplotype modulates Alzheimer beta-amyloid deposition in the brain. American Journal of Medical Genetics, 114, pp. 288-291.
67. Pankhe, J., Walker, LC and Schroeder, E. (2003) Cerebral beta-amyloid deposition is augmented by the -491 AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele. Acta Neuropathologica, 105, pp. 25-29.
68. Teter, B. (2004) ApoE-dependent plasticity in Alzheimer's disease. Journal of Molecular Neuroscience, 23, pp. 167-179.
69. Brandstack, N., Kurki, T., Tenovuo, O. and Isoniemi, H. (2006) MR imaging of head trauma: Visibility of contusions and other intraparenchymal injuries in early and late stage. Brain Injury, 20, pp. 409-416.
70. Isoniemi, H., Kurki, T., Tenovuo, O., Kairisto, V. and Portin, R. (2006) Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology, 67, pp. 756-760.